Mukka Proteins Limited has published a newspaper advertisement pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying stakeholders of its audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. The advertisement was published on Saturday, 16 May 2026, in compliance with applicable regulatory disclosure requirements.

Regulatory Compliance and Publication Details

The newspaper advertisement was published in two publications to ensure broad dissemination to investors and the general public. The key publication details are summarised below:

Board Approval and Availability of Results

Based on the recommendation of the Audit Committee, the Board of Directors of Mukka Proteins Limited approved the audited standalone and consolidated financial results at its meeting held on 15 May 2026. The full financial results, along with the Independent Auditor's Report of the Statutory Auditors, are available through the following channels:

• Company Website: https://mukkaproteins.com/wp-content/uploads/2026/05/Outcome_of_Board_Meeting_15-05-2026_final.pdf
• BSE Limited: www.bseindia.com
• National Stock Exchange of India Limited: www.nseindia.com
• QR Code: Available in the published advertisement for direct access

Certification and Signatory Details

The regulatory communication was submitted to both the National Stock Exchange of India Limited and BSE Limited. The advertisement notice was signed by Mehaboobsab Mahmadgous Chalyal, Company Secretary & Compliance Officer (Membership No.: A67502), on behalf of the Board of Directors of Mukka Proteins Limited. The filing was digitally signed on 16 May 2026.

The notice was signed on behalf of the Board of Directors by Kalandan Mohammed Haris, Managing Director & CEO, from Mangaluru, dated 15 May 2026. Mukka Proteins Limited holds ISO 22000 and ISO 9001:2015 certifications, reflecting its commitment to quality and food safety management standards.

Mukka proteins Limited has submitted its quarterly compliance certificate to both NSE and BSE for the quarter ended 31st March 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The company filed the mandatory certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on 07th April 2026. Company Secretary and Compliance Officer Mehaboobsab Mahmadgous Chalyal signed and submitted the documentation to ensure regulatory compliance.

Share Transfer Agent Confirmation

Cameo Corporate Services Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate confirming operational status during the quarter. The registrar confirmed that no demat requests were received for processing during Q4 FY26, indicating that all company shares remain in electronic format.

Complete Electronic Share Structure

The certificate highlights that Mukka Proteins Limited maintains a fully digitized shareholding structure with no physical share certificates in circulation. This complete electronic format eliminates the need for dematerialization requests and streamlines share transfer processes.

Stock Exchange Communication

The compliance certificate was simultaneously submitted to both major Indian stock exchanges where Mukka Proteins Limited shares are listed. The company maintains active listings and ensures timely regulatory disclosures to keep investors informed about compliance matters.